News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VertiFlex Announces 200 Patients Enrolled in Superion(R) IDE Trial



10/15/2010 11:31:44 AM

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--VertiFlex, Inc., a leading innovator of minimally invasive and motion preserving spinal surgery technologies, today announced that 200 patients have been enrolled in its pivotal IDE clinical trial of the Superion® Interspinous Spacer (ISS).

Read at BioSpace.com


comments powered by Disqus
VertiFlex
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES